INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

105 hedge funds and large institutions have $145M invested in Inozyme Pharma in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 19 closing their positions.

Holders
105
Holders Change
+16
Holders Change %
+17.98%
% of All Funds
1.4%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
35
Increased
34
Reduced
17
Closed
19
Calls
$7K
Puts
$15K
Net Calls
-$8K
Net Calls Change
+$6K

Top Buyers

1
AAA
1
Affinity Asset Advisors
New York
$11M
2
Citadel Advisors
2
Citadel Advisors
Florida
$1.71M
3
S
3
Sanofi
France
$1.23M
4
BlackRock
4
BlackRock
New York
$10.6M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.17M

Top Sellers

1
SC
1
Samlyn Capital
New York
$0
2
EAM
2
Eventide Asset Management
Massachusetts
$6.15M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.05M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$14.3M
5
Goldman Sachs
5
Goldman Sachs
New York
$700K
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$14.3M 5,160,000 -513,629 -9%
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$12.5M 4,494,851 – –
SI
3
Sofinnova Investments
California
$11.9M 4,280,308 – –
AAA
4
Affinity Asset Advisors
New York
$11M 3,972,318 +1,150,000 +41%
RSCM
5
Rock Springs Capital Management
Maryland
$10.7M 3,861,983 +59,100 +2%
BlackRock
6
BlackRock
New York
$10.6M 3,812,539 +321,303 +9%
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.29M 2,633,249 +8,911 +0.3%
NMC
8
NEA Management Company
Maryland
$6.75M 2,437,689 – –
EAM
9
Eventide Asset Management
Massachusetts
$6.15M 2,220,000 -1,914,436 -46%
Millennium Management
10
Millennium Management
New York
$5.21M 1,882,274 +137,821 +8%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$5.05M 1,824,458 -654,231 -26%
SB
12
Samsara BioCapital
California
$4.33M 1,562,500 – –
SVCM
13
Saturn V Capital Management
Texas
$3.81M 1,374,582 +5,772 +0.4%
SFM
14
Sphera Funds Management
Israel
$3.3M 1,191,140 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$3.27M 1,179,622 +8,450 +0.7%
BOCH
16
Blue Owl Capital Holdings
New York
$2.99M 1,080,027 -40,000 -4%
State Street
17
State Street
Massachusetts
$2.79M 1,007,455 -42,965 -4%
WP
18
Woodline Partners
California
$2.78M 1,003,124 – –
DMKJ
19
David M. Knott Jr
$1.93M 695,000 +130,451 +23%
Citadel Advisors
20
Citadel Advisors
Florida
$1.71M 616,909 +567,349 +1,145%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$1.4M 504,670 +58,518 +13%
Northern Trust
22
Northern Trust
Illinois
$1.25M 450,764 +11,919 +3%
S
23
Sanofi
France
$1.23M 443,255 +443,255 New
Renaissance Technologies
24
Renaissance Technologies
New York
$1.17M 421,399 +256,599 +156%
Goldman Sachs
25
Goldman Sachs
New York
$700K 252,722 -194,595 -44%
1
2 3 4 5